What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Francesco Bertoni spends much of his time researching Lymphoma, Cancer research, Internal medicine, Immunology and Pathology.
His Lymphoma study combines topics from a wide range of disciplines, such as Helicobacter pylori and Marginal zone.
His Cancer research study integrates concerns from other disciplines, such as Genetics, Mutation, Mantle cell lymphoma, B cell and Molecular biology.
Within one scientific family, he focuses on topics pertaining to Gastroenterology under Internal medicine, and may sometimes address concerns connected to Minimal residual disease, Rituximab, Surgery and Chemotherapy.
As a member of one scientific family, Francesco Bertoni mostly works in the field of Immunology, focusing on Oncology and, on occasion, Hazard ratio, Genetic testing, DNA Mutational Analysis, Genetic model and Gene mutation.
His research investigates the link between Pathology and topics such as Immunophenotyping that cross with problems in Lymphatic system.
His most cited work include:
- Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. (1052 citations)
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma (815 citations)
- Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation (485 citations)
What are the main themes of his work throughout his whole career to date?
Francesco Bertoni focuses on Cancer research, Lymphoma, Diffuse large B-cell lymphoma, Internal medicine and Pathology.
His Cancer research research is multidisciplinary, incorporating elements of Cancer, Cell cycle, Idelalisib, Ibrutinib and Mantle cell lymphoma.
Lymphoma is a subfield of Immunology that Francesco Bertoni studies.
Chronic lymphocytic leukemia is the focus of his Immunology research.
The Internal medicine study combines topics in areas such as Gastroenterology, Surgery and Oncology.
His work focuses on many connections between B cell and other disciplines, such as Molecular biology, that overlap with his field of interest in Cell culture and Genetics.
He most often published in these fields:
- Cancer research (43.31%)
- Lymphoma (39.74%)
- Diffuse large B-cell lymphoma (19.40%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (43.31%)
- Lymphoma (39.74%)
- Diffuse large B-cell lymphoma (19.40%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Lymphoma, Diffuse large B-cell lymphoma, Venetoclax and Cell culture.
His studies in Cancer research integrate themes in fields like Transcriptome, Mantle cell lymphoma, Ibrutinib, B cell and PI3K/AKT/mTOR pathway.
His biological study focuses on Follicular lymphoma.
His Diffuse large B-cell lymphoma research is multidisciplinary, relying on both breakpoint cluster region and BCL6.
He studied Cell culture and Molecular biology that intersect with Mechanism of action.
In his research on the topic of Gene expression profiling, Leukemia is strongly related with Mutation.
Between 2018 and 2021, his most popular works were:
- Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma (51 citations)
- KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study (28 citations)
- Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia. (21 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Francesco Bertoni mainly investigates Cancer research, Lymphoma, Diffuse large B-cell lymphoma, Mutation and Venetoclax.
His Cancer research research incorporates elements of Cell growth, Mantle cell lymphoma, Follicular lymphoma, Leukemia and Bruton's tyrosine kinase.
In his study, B cell is inextricably linked to Cell cycle, which falls within the broad field of Follicular lymphoma.
Francesco Bertoni interconnects Genetics, In vivo, Gene expression profiling, Transcriptome and Epigenetics in the investigation of issues within Lymphoma.
His Diffuse large B-cell lymphoma study incorporates themes from High incidence and Clinical course.
His Mutation research is multidisciplinary, incorporating perspectives in Oncology, Chemoimmunotherapy and Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
